Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.
Authors:
- 1 February 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 87 (2) , 454-463
Abstract
BACKGROUND: In chronic heart failure, the positive inotropic effects of beta-adrenergic receptor agonists are greatly reduced, in part as a result of two alterations of the cardiac beta-adrenergic receptors: loss of their function (receptor uncoupling) and reduction of their number (downregulation). In vitro studies have shown that a major mechanism leading to beta-adrenergic receptor uncoupling involves phosphorylation of the receptors by the specific beta-adrenergic receptor kinase (beta ARK). METHODS AND RESULTS: We have therefore investigated expression of beta ARK and beta-adrenergic receptors in samples from the left ventricles of patients with dilated cardiomyopathy or ischemic cardiomyopathy and from nonfailing control ventricles. Contractile responses to beta-receptor stimulation were decreased in the failing hearts compared with control hearts, whereas those to forskolin and calcium remained unchanged. The messenger RNA (mRNA) levels of beta ARK, beta 1- and beta 2-receptors, and of glyceraldehyde phosphate dehydrogenase and beta-actin as controls were measured by quantitative polymerase chain reactions. In addition, beta ARK enzyme activity assays were performed, and the levels of beta 1- and beta 2-receptors were determined by radioligand binding. beta ARK mRNA levels were increased almost threefold in both forms of heart failure, and beta ARK activity was enhanced. beta 1-Receptor mRNA levels and beta 1-receptor numbers were decreased by approximately 50% in both failing groups, whereas these levels were unaltered for beta 2-receptors. There were no differences between dilated and ischemic cardiomyopathy for any of these parameters. CONCLUSIONS: In addition to other alterations found in failing hearts, the diminished response to beta-receptor agonists appears to involve the combined effects of enhanced expression of beta ARK and reduced expression of beta 1-receptors.Keywords
This publication has 29 references indexed in Scilit:
- Regulation of receptor expression by agonists: transcriptional and post-transcriptional controlsTrends in Neurosciences, 1991
- cDNA cloning and chromosomal localization of the human α‐adrenergic receptor kinaseFEBS Letters, 1991
- β-Arrestin: a Protein that Regulates β-adrenergic Receptor FunctionScience, 1990
- β-Blocking Agents and Positive Inotropic Agents in the Therapy of Chronic Heart FailureJournal of Cardiovascular Pharmacology, 1990
- Phosphorylation of chick heart muscarinic cholinergic receptors by the .beta.-adrenergic receptor kinaseBiochemistry, 1989
- Pharmacology and inotropic potential of forskolin in the human heart.Journal of Clinical Investigation, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Light-dependent phosphorylation of rhodopsin: number of phosphorylation sitesBiochemistry, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970